EurekaSystems Secures Series A Funding Led by SoftBank China Venture Capital to Advance Healthcare Data Platform

Recently, Eureka Systems, a leading domestic medical big data and smart healthcare company, successfully completed its first round of financing, led by SoftBank China Capital.

Eureka Systems, established in 2014, is a leading medical big data company in China and a pioneering innovator in the fields of medical big data and smart healthcare. This round marks the company’s first financing since its inception.This round of financing marks Eureka Systems’ entry into a phase of rapid growth, ushering in a new chapter.

As the first company in China to introduce a “middle-platform solution” featuring an integration platform and data center designed to address hospital IT architecture and data silo issues, Eureka Systems has established this solution as the “architectural backbone” for building smart hospitals. By leveraging the “dual-wheel strategy” centered on achieving high ratings in the “Interconnectivity Evaluation” and “Electronic Medical Record (EMR) Grading Assessment,” the company promotes the standardized development of “smart hospitals.”Eureka Systems has to date provided integration platform and data center solutions to more than 200 Grade IIIA hospitals in China.solutions and a comprehensive suite of smart hospital products centered on electronic medical records, adopted by top-10 hospitals nationwide, including The First Affiliated Hospital of Sun Yat-sen University, Ruijin Hospital affiliated with Shanghai Jiao Tong University, and Huashan Hospital affiliated with Fudan University,Covering more than 17 provinces across China, with a presence in East China, Central China, South China, Southwest China, and the Shandong-Hebei region.。

Dr. Zhou Qi, Founder of Eureka Systems, Head and Neck Surgeon at Fudan University, and former Healthcare Industry Director at Microsoft Consulting Services, stated: “The trend toward younger demographics in chronic diseases and cancer, coupled with an aging society, is increasingly challenging the cost, efficiency, and quality of healthcare service providers, as well as current disease management models. There is an urgent need for precision medicine driven by medical big data and refined hospital operational management to become the core themes in the development of smart healthcare. This round of financing will accelerate the development of Eureka Systems’ Smart Hospital Middle Platform, promote the closed-loop R&D of medical big data applications, and expand multi-line business layouts, thereby providing healthcare institutions with more efficient and secure next-generation smart healthcare solutions and their extended applications. Leveraging data-driven strategies and AI empowerment, Eureka Systems will deliver more comprehensive tools and technical services to hospitals, patients, and the broader healthcare landscape in China.”

Mr. Jiang Min, Partner at SoftBank China Capital, stated, “SoftBank China remains bullish on the empowerment of healthcare through big data and its future applications. Eureka Systems is a leading domestic company in medical big data and smart healthcare, with its business layout, technological reserves, and innovation potential ranking at the forefront in China and pioneering new paths in the industry. The founder, Dr. Zhou Qi, has accumulated extensive industry experience through years of work in clinical surgical roles and at Microsoft’s Healthcare Division, making him a pioneer in the fields of medical big data and smart healthcare. We look forward to Eureka Systems, under Dr. Zhou Qi’s leadership, making new contributions to China’s medical big data industry.”

Eureka Systems (Shanghai) Information Technology Co., Ltd. was established in 2014 and is a provider of comprehensive solutions for medical big data and smart healthcare in China. Guided by its corporate philosophy, “Trustworthy Medical Data Value Chain (Data Aggregates Healthcare, Value Links the Future),” the company focuses on delivering professional and reliable data services and an open IT ecosystem to hospitals. Since its inception, it has been recognized as a National High-Tech Enterprise, a Shanghai “Little Giant” enterprise, and a leading brand in medical big data.Eureka Systems serves over 200 clients in China, empowering the development of new platforms and ecosystems for smart healthcare.

SoftBank China Capital (SBCVC), established in 2000, is a leading venture capital and private equity fund management firm dedicated to investing in high-growth, high-tech enterprises across the Greater China region. It has successfully invested in a portfolio of outstanding companies, including Alibaba, Taobao, Focus Media, GDS Holdings, BGI Genomics, Dian Diagnostics, and Edan Instruments. Currently, SoftBank China Capital manages multiple USD and RMB funds, with investment sectors spanning information technology, healthcare, clean technology, consumer retail, and advanced manufacturing, covering investment stages from early-stage to growth-stage and late-stage.